BIRC2 and cancer: In addition, NF-kB signaling, one of the major pathways known to be constitutively activated in many cancers was found to be inhibited by GS in HCT 116 cells from the current study, as lowered expression of Bcl-2, cIAP-1, and survivin (the NF-kB target genes) were observed with GS treatment.